Foli Bio Inc.
- Biotech or pharma, therapeutic R&D
- Diagnostics
Foli Bio is pioneering a next-generation transcriptomics and immune profiling platform to advance drug development and precision medicine. We have discovered that exfoliated biological material, such as stool, serves as a rich yet untapped reservoir of biological signals, offering unique insights into human health.
Leveraging our proprietary Foli-seq technology, we have, for the first time, enabled robust, high-sensitivity analysis of the gut transcriptome from ultra-rare human RNA signals in stool. This breakthrough empowers pharmaceutical companies to accelerate drug discovery and development by providing unprecedented, non-invasive insights into gastrointestinal and immune health and transforming precision medicine for immune-related diseases.
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}